e.g. Tata motors, Reliance MF, 500570

AstraZeneca Pharma India Ltd. - Research Center

506820 ASTRAZEN Group (A) BSE data
 
Back to Company Page
Statement:

Balance sheet

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Sources of funds
Owner's fund
Equity share capital 5.00 5.00 5.00 5.00 5.00
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 765.35 706.92 583.69 506.39 451.17
Loan funds
Secured loans - - - - -
Unsecured loans - - - - -
Total 770.35 711.92 588.69 511.39 456.17
Uses of funds
Fixed assets
Gross block 216.03 171.75 165.14 158.64 159.78
Less : revaluation reserve - - - - -
Less : accumulated depreciation 151.79 105.07 96.28 84.15 78.82
Net block 64.24 66.68 68.86 74.49 80.96
Capital work-in-progress - 0.27 1.33 2.20 4.02
Investments - - - - -
Net current assets
Current assets, loans & advances 1,453.88 1,011.08 914.68 779.87 689.73
Less : current liabilities & provisions 747.77 366.11 396.18 345.17 318.54
Total net current assets 706.11 644.97 518.50 434.70 371.19
Miscellaneous expenses not written - - - - -
Total 770.35 711.92 588.69 511.39 456.17
Notes:
Book value of unquoted investments - - - - -
Market value of quoted investments - - - - -
Contingent liabilities 98.51 138.25 132.28 124.60 89.17
Number of equity sharesoutstanding (Lacs) 250.00 250.00 250.00 250.00 250.00
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback